[go: up one dir, main page]

SG11201907398TA - Conjugate of salicylic acid and peptide - Google Patents

Conjugate of salicylic acid and peptide

Info

Publication number
SG11201907398TA
SG11201907398TA SG11201907398TA SG11201907398TA SG11201907398TA SG 11201907398T A SG11201907398T A SG 11201907398TA SG 11201907398T A SG11201907398T A SG 11201907398TA SG 11201907398T A SG11201907398T A SG 11201907398TA SG 11201907398T A SG11201907398T A SG 11201907398TA
Authority
SG
Singapore
Prior art keywords
salicylic acid
peptide
compound
conjugate
antibacterial
Prior art date
Application number
SG11201907398TA
Inventor
Yong Ji Chung
Eun Mi Kim
Original Assignee
Caregen Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Caregen Co Ltd filed Critical Caregen Co Ltd
Publication of SG11201907398TA publication Critical patent/SG11201907398TA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

CONJUGATE OF SALICYLIC ACID AND PEPTIDE The present invention relates to an antibacterial, anti-inflammatory, or antioxidant composition and, more specifically, to a compound having a structure in which salicylic acid is linked to a peptide via a covalent linkage, and to an antibacterial, anti-inflammatory, or antioxidant pharmaceutical or cosmetic composition containing the compound. The compound having a structure in which salicylic acid is linked to a peptide via a covalent linkage, of the present invention, has excellent physiological activity, such as antibacterial, anti-inflammatory, or antioxidant activity, as well as excellent characteristics, such as solubility in water, and thus the compound can be favorably used in various fields of food, drug, or cosmetics. [Figure 1]
SG11201907398TA 2017-02-16 2017-02-16 Conjugate of salicylic acid and peptide SG11201907398TA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2017/001725 WO2018151352A1 (en) 2017-02-16 2017-02-16 Conjugate of salicylic acid and peptide

Publications (1)

Publication Number Publication Date
SG11201907398TA true SG11201907398TA (en) 2019-09-27

Family

ID=63170679

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201907398TA SG11201907398TA (en) 2017-02-16 2017-02-16 Conjugate of salicylic acid and peptide

Country Status (13)

Country Link
US (1) US10874709B2 (en)
EP (1) EP3583944A4 (en)
JP (2) JP6983247B2 (en)
CN (1) CN110520162B (en)
AU (1) AU2017399481B2 (en)
BR (1) BR112019016910A2 (en)
CA (1) CA3053321C (en)
EA (1) EA201991699A1 (en)
MX (1) MX2019009627A (en)
PH (1) PH12019501839A1 (en)
SG (1) SG11201907398TA (en)
WO (1) WO2018151352A1 (en)
ZA (1) ZA201905738B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria
KR102221365B1 (en) * 2019-05-07 2021-03-02 (주)케어젠 Trolox Peptide Conjugate and Use Thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2782269B1 (en) 1998-08-17 2001-08-31 Oreal COSMETIC AND / OR DERMATOLOGICAL COMPOSITION CONTAINING SALICYLIC ACID OR A SALICYLIC ACID DERIVATIVE AND USE THEREOF
US7060708B2 (en) * 1999-03-10 2006-06-13 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US8394813B2 (en) * 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
CN1649614A (en) * 2002-02-22 2005-08-03 新河药品股份有限公司 Active agent delivery systems and methods for protecting and administering active agents
KR100716119B1 (en) * 2005-10-24 2007-05-10 (주)케어젠 Peptides Promoting Hair Growth and Cosmetics Using the Same
CN101426468B (en) 2006-04-18 2012-02-08 帝斯曼知识产权资产管理有限公司 Cosmetic compositions comprising salicylic acid and ascorbic acid
US8183212B2 (en) 2006-04-26 2012-05-22 Kyoto University Compound having GPR54 agonistic activity
KR101021197B1 (en) 2008-04-11 2011-03-11 (주)케어젠 Growth Factors—Micking Peptides and Uses thereof
KR101163171B1 (en) * 2009-01-20 2012-07-19 (주)케어젠 Noggin derived Peptides and Uses Thereof
KR101198918B1 (en) 2009-09-01 2012-11-07 (주)케어젠 WNT10 Derived Peptides and Uses Thereof
US9700633B2 (en) * 2013-01-28 2017-07-11 Jenkem Technology Co., Ltd., Tianjin Branch Conjugates of water soluble polymer-amino acid oligopeptide-drug, preparation method and use thereof
KR20140107784A (en) 2013-02-28 2014-09-05 주식회사 크라운진 Composition for preventing falling out of the hair and promoting growth of the hair
KR101527280B1 (en) 2013-07-23 2015-06-09 주식회사 바이오에프디엔씨 Novel Peptide derivatives from Jellyfish Extract and Composition for Skin External Application Comprising the Same
WO2015054006A2 (en) * 2013-10-11 2015-04-16 Tarix Pharmaceuticals Ltd. Novel peptide compositions
JP2014114291A (en) * 2013-12-13 2014-06-26 Showa Denko Kk Cosmetic and skin external preparation
JP2016222612A (en) * 2015-06-01 2016-12-28 昭和電工株式会社 Cosmetic and skin external preparation

Also Published As

Publication number Publication date
EA201991699A1 (en) 2020-01-21
CN110520162A (en) 2019-11-29
CN110520162B (en) 2023-02-17
WO2018151352A1 (en) 2018-08-23
JP2020508988A (en) 2020-03-26
PH12019501839A1 (en) 2020-03-09
CA3053321C (en) 2023-03-21
EP3583944A4 (en) 2021-03-03
AU2017399481B2 (en) 2020-05-07
AU2017399481A1 (en) 2019-09-05
ZA201905738B (en) 2023-09-27
CA3053321A1 (en) 2018-08-23
US20190374599A1 (en) 2019-12-12
JP2021176330A (en) 2021-11-11
MX2019009627A (en) 2019-12-11
JP6983247B2 (en) 2021-12-17
US10874709B2 (en) 2020-12-29
EP3583944A1 (en) 2019-12-25
BR112019016910A2 (en) 2020-05-26

Similar Documents

Publication Publication Date Title
EP4442241A3 (en) Retinol replacement in skin treatment
CA2894892A1 (en) Boronic acid derivatives and therapeutic uses thereof
CA2894891A1 (en) Boronic acid derivatives and therapeutic uses thereof
TW200716661A (en) A novel triterpenic acid derivative and the skin external preparation containing the same
MX366773B (en) Topical wash composition for use in acne patients.
EP4342532A3 (en) Antiplatelet drugs and uses thereof
EA201291089A1 (en) METHOD FOR OBTAINING PHARMACEUTICAL PREPARATIONS INTENDED FOR ORAL ADMINISTRATION, CONTAINING ONE OR MORE ACTIVE INGREDIENTS AND CONTAINING COMPOSITIONS
MX2010004613A (en) Topical composition.
WO2017155232A3 (en) Peptide exhibiting hair growth promoting activity and/or melanin production promoting activity and use thereof
WO2021129617A3 (en) Topical composition for preventing, alleviating, or treating skin allergies, and use therefor
WO2017037075A8 (en) Composition containing echinacea extract and linoleic acid derivatives
PH12013502215A1 (en) Beautiful-skin-promoting agent and use thereof
PH12016501103A1 (en) Acid-solubilized copper-ammonium complexes and copper-zinc-ammonium complexes, compositions, preparations, methods, and uses
EA201891235A1 (en) COMPOSITIONS OF MEDICINES FOR THE TREATMENT OF MALIGNANT TUMOR
EA201790223A1 (en) WATER PREPARATION CONTAINING PARACETAMOL AND IBUPROFEN
SA518400042B1 (en) Conjugate of finasteride with peptide
ZA201905738B (en) Conjugate of salicylic acid and peptide
ZA202307290B (en) Pyrazolopyridine derivatives and uses thereof
WO2012152940A3 (en) Small molecule inhibitors of trpa1
PH12019502514A1 (en) Conjugate of isotretinoin and peptide
MX2015014905A (en) PYRAZINO[1,2-a]INDOLE COMPOUNDS, THEIR PREPARATION AND USE IN MEDICAMENTS.
WO2016195194A3 (en) Novel tlr2 antagonists
MX2021008812A (en) Cosmetic/dermatological composition.
PH12015502420A1 (en) PYRAZINO[1,2-a]INDOLE COMPOUNDS, THEIR PREPARATION AND USE IN MEDICAMENTS
WO2019083286A3 (en) Composition comprising irone as active ingredient for preventing hair loss or stimulating new hair growth